Reviewing Diagnosis and Management Strategies for Barrett's Esophagus
Keywords:
BE (Barrette oesophagus), GERD (Gastroesophageal reflux disorder) Intestinal metaplasia (IM), AGA (American college of gastroenterology)Abstract
Incidence of distal oesophageal carcinoma is increasing faster than that of any other visceral cancer in the western world. It is commonly known that the most, if not all, of theses tumours arise in the Barrette oesophagus through the metaplasia-dysplasia-carcinoma sequence. Which may allow for early detection; nonetheless, most of these tumours are still discovered much late in their progression. This emphasizes how far of the aim of adequate surveillance for patients at risk of distal oesophageal cancer is developed. BE is a metaplastic alteration of the oesophageal mucosa , distinguished by the presence of goblet cells in columnar epithelium and salmon coloured lining. Oesophageal adenocarcinoma is a well-known precancerous condition with extremely low survival rates whose occurrence is rising quickly. The controversy around its diagnosis and treatment persists despite a wealth of research. This article is to give a summary of recent findings and recommendations related to the topicReferences
Michopoulos S. Critical appraisal of guidelines for screening and surveillance of Barrett's oesophagus. Ann Transl Med. 2018 Jul; 6(13):259. [PMC free article] [PubMed]
Nowicki A, Kula Z, Świerszczyńska A. Barrett's esophagus and gland cancer - the experience of one center. Pol Przegl Chir. 2018 May 16; 90(3):19-24. [PubMed]
Dewan KR, Patowary BS, Bhattarai S, Shrestha G. Barrett's Esophagus in Patients with Gastroesophageal Reflux Disease. J Nepal Health Res Counc. 2018 Jul 03; 16(2):144-148. [PubMed]
Oh D.S., Demeester S.R. Pathophysiology and treatment of Barrett’s esophagus. World J. Gastroenterol. 2010; 16:3762–3772. doi: 10.3748/wjg.v16.i30.3762. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Oberg S., Peters J.H., DeMeester T.R., Chandrasoma P., Hagen J.A., Ireland A.P., Ritter M.P., Mason R.J., Crookes P., Bremner C.G.
Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann. Surg. 1997; 226:522–530. doi: 10.1097/00000658-199710000-00013. Discussion
–532. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Tobey N.A., Hosseini S.S., Argote C.M., Dobrucali A.M., Awayda M.S., Orlando R.C. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am. J.
Gastroenterol. 2004; 99:13–22. doi: 10.1046/j.1572-
2003.04018.x. [PubMed] [CrossRef] [Google Scholar]
Oberg S., Johansson J., Wenner J., Walther B. Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann. Surg. 2002; 235:338–345. doi: 10.1097/00000658-200203000-00005. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Chandrasoma P. Controversies of the cardiac mucosa and Barrett’s oesophagus. Histopathology. 2005; 46:361–373. doi: 10.1111/j.1365-
2005.02088.x. [PubMed] [CrossRef] [Google Scholar]
Reid B.J., Sanchez C.A., Blount P.L., Levine D.S. Barrett’s esophagus: Cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology. 1993; 105:119–129. doi: 10.1016/0016-
(93)90017-7. [PubMed] [CrossRef] [Google Scholar]
Akın H, Aydın Y. How should we describe, diagnose and observe the
Barrett's esophagus? Turk J Gastroenterol. 2017 Dec; 28(Suppl 1):S26S30. [PubMed]
Beg S, Ragunath K, Wyman A, Banks M, Trudgill N, Pritchard DM, Riley S, Anderson J, Griffiths H, Bhandari P, Kaye P, Veitch A. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland
(AUGIS). Gut. 2017 Nov; 66(11):1886-1899. [PMC free article] [PubMed]
Markar SR, Arhi C, Leusink A, Vidal-Diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB. The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study. Ann Surg. 2018 Nov; 268(5):861-867. [PubMed]
Ali Khan M, Howden CW. The Role of Proton Pump Inhibitors in the
Management of Upper Gastrointestinal Disorders. Gastroenterol
Hepatol (N Y). 2018 Mar; 14(3):169-175. [PMC free article] [PubMed]
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
